This country profile provides an overview of Zimbabwe’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
48%
Blinding trachoma
0%
Intestinal worms
49%
Bilharzia
100%
River blindness
N/A
4.92 million people received treatment in Zimbabwe in 2017 5.74 million people did not receive treatment in Zimbabwe in 2017

Priorities for progress in Zimbabwe

  • Zimbabwe should work to address the reasons for the fluctuating coverage rates for all the endemic diseases, in order to consistently achieve recommended WHO coverage targets.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage decreased from 79% in 2016 to 48% in 2017.

People needing treatment
7.68m
People receiving treatment
3.71m

Blinding trachoma

Treatment coverage decreased from 7% in 2016 to 0% in 2017.

People needing treatment
1.66m
People receiving treatment
0m

Intestinal worms

Treatment coverage decreased from 75% in 2016 to 49% in 2017.

Pre-sch and school-aged children needing treatment
5.85m
Pre-school and school-aged children receiving treatment
2.89m

Bilharzia

Treatment coverage increased from 93% in 2016 to 100% in 2017.

School-aged children needing treatment
2.83m
School-aged children receiving treatment
2.83m

River blindness

Zimbabwe does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Zimbabwe.